Literature DB >> 11892071

The hyper IgM syndrome.

R L Fuleihan1.   

Abstract

The hyper IgM syndrome is a rare, inherited immune deficiency disorder resulting from defects in the CD40 ligand/CD40-signaling pathway. X-linked hyper IgM is caused by defects in the CD40 ligand gene, while autosomal recessive hyper IgM is caused by defects in the CD40-activated RNA-editing enzyme, activation-induced cytidine deaminase, which is required for immunoglobulin isotype switching and somatic hypermutation in B cells. The loss of interaction between CD40 and its ligand in X-linked hyper IgM results in an impairment of T cell function, of B cell differentiation, and of monocyte function, while only B cell differentiation appears to be affected in autosomal recessive hyper IgM. With genetic defects in the hyper IgM syndrome identified, it is possible to diagnose patients definitely, to perform genetic screening, and to delineate the clinical manifestations of this syndrome. Further research may lead to novel and definitive therapeutic options for patients with hyper IgM syndrome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11892071     DOI: 10.1007/s11882-001-0030-6

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  48 in total

1.  Clinical spectrum of X-linked hyper-IgM syndrome.

Authors:  J Levy; T Espanol-Boren; C Thomas; A Fischer; P Tovo; P Bordigoni; I Resnick; A Fasth; M Baer; L Gomez; E A Sanders; M D Tabone; D Plantaz; A Etzioni; V Monafo; M Abinun; L Hammarstrom; T Abrahamsen; A Jones; A Finn; T Klemola; E DeVries; O Sanal; M C Peitsch; L D Notarangelo
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

2.  CD40 and its crucial role as a member of the TNFR family.

Authors:  L A Vogel; R J Noelle
Journal:  Semin Immunol       Date:  1998-12       Impact factor: 11.130

Review 3.  The role of CD40 ligand in costimulation and T-cell activation.

Authors:  I S Grewal; R A Flavell
Journal:  Immunol Rev       Date:  1996-10       Impact factor: 12.988

4.  CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization.

Authors:  G de Saint Basile; M D Tabone; A Durandy; F Phan; A Fischer; F Le Deist
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

5.  Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome.

Authors:  A Jain; T P Atkinson; P E Lipsky; J E Slater; D L Nelson; W Strober
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

6.  CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand.

Authors:  K Seyama; W R Osborne; H D Ochs
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

7.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Hyper IgM syndrome associated with defective CD40-mediated B cell activation.

Authors:  M E Conley; M Larché; V R Bonagura; A R Lawton; R H Buckley; S M Fu; E Coustan-Smith; H G Herrod; D Campana
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

9.  CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation.

Authors:  E Castigli; F W Alt; L Davidson; A Bottaro; E Mizoguchi; A K Bhan; R S Geha
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

10.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

View more
  3 in total

Review 1.  The hyper IgM syndromes.

Authors:  Nashmia Qamar; Ramsay L Fuleihan
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

2.  A novel polymorphism of the human CD40 receptor with enhanced function.

Authors:  Anna L Peters; Robert M Plenge; Robert R Graham; David M Altshuler; Kathy L Moser; Patrick M Gaffney; Gail A Bishop
Journal:  Blood       Date:  2008-06-30       Impact factor: 22.113

3.  CD40L disruption enhances Abeta vaccine-mediated reduction of cerebral amyloidosis while minimizing cerebral amyloid angiopathy and inflammation.

Authors:  D Obregon; H Hou; Y Bai; W V Nikolic; T Mori; Deyan Luo; J Zeng; J Ehrhart; F Fernandez; D Morgan; B Giunta; T Town; J Tan
Journal:  Neurobiol Dis       Date:  2007-10-16       Impact factor: 5.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.